Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

NCT05470413 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: SHR0302
DRUG: SHR0302
DRUG: Placebo

Sponsor

Reistone Biopharma Company Limited